MAFM
MRNA icon

Mid Atlantic Financial Management’s Moderna MRNA Stock Holding History

Mid Atlantic Financial Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.98M Buy
5,135
+72
+1% +$26.6K 0.13% 145
2021
Q2 		$1.19M Sell
5,063
-259
-5% -$46.3K 0.08% 207
2021
Q1 		$697K Sell
5,322
-125
-2% -$18.1K 0.05% 346
2020
Q4 		$569K Sell
5,447
-1,204
-18% -$122K 0.04% 356
2020
Q3 		$517K Sell
6,651
-750
-10% -$52.3K 0.05% 345
2020
Q2 		$475K Buy
+7,401
New +$405K 0.05% 348

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Mid Atlantic Financial Management's MRNA Position: Q3 2021 in Review

Mid Atlantic Financial Management increased its Moderna (MRNA) stake by 1.4% in Q3 2021, buying an estimated $26.6K and bringing the position to 5,135 shares worth $1.98M. The position accounts for 0.13% of the portfolio, ranked #145.

Mid Atlantic Financial Management first reported a position in MRNA in Q2 2020 and has held it in 6 quarters since. 1,141 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • Mid Atlantic Financial Management held 5,135 shares of Moderna worth $1.98M as of Q3 2021.
  • Mid Atlantic Financial Management bought 72 Moderna shares in Q3 2021, an estimated $26.6K.
  • Moderna made up 0.13% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #145 holding.
  • Mid Atlantic Financial Management first reported a position in Moderna in Q2 2020 and has held it in 6 quarters since.
  • 1,141 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.